Patients in intensive care require high quality nutritional support to enhance recovery. Provision of the optimal amount of trace elements and vitamins is especially difficult, partly because of the variable requirements to meet abnormal losses and hypermetabolism, and also due to the uncertainty regarding the benefit of large antioxidant supplements, many micronutrient being key antioxidants. This presentation will address three topical areas. Patients in ICU with sepsis consistently have poor selenium status. Early studies suggested that high dose selenium would reduce the incidence of renal failure. In a trial on 40 patients in our ICU we found no significant difference in mortality or renal failure despite improvement in selenium status. A recent multicentre study with high dose intravenous selenium suggests improved mortality in the most severely ill patients with disseminated intravascular coagulation. In a further study we have demonstrated that patients who do not survive their stay in ICU have higher levels of oxidative damage as reflected in plasma malondialdehyde and F2 isoprostane concentrations. In a trial of 5 days high dose antioxidant provision (Se/Zn/VitaminC/VitaminE) in 200 patients with cardiac surgery/trauma/ subarachnoid haemorrhage, there was no effect on mortality, and the only group to show a benefit in terms of duration of stay in ICU were those with severe trauma and no head injury. Patients with burns have particularly high requirements due to losses through the skin. In a series of studies with colleagues in Lausanne, high dose intravenous zinc/copper/ selenium supplements intravenously reduced infectious complications, especially nosocomial pneumonia, and improved wound healing, with increased blood and skin concentrations of these elements. Several major questions remain-under what circumstances do high dose micronutrients produce clinical benefits and what is the optimal amount of each trace element and vitamin-and what is the best way to monitor adequacy of provision, perhaps by using intracellular concentrations rather than plasma, and with markers of oxidative damage.
Sepsis is an emergent health problem. It's a problem which account for up to 25% of ICU admissions. Though no corresponding Indian data is available but in the USA, sepsis is the cause of over 2 million annual deaths, while in Europe it causes over 1.5 million annual deaths (Crit Care Med 2001; 29; 1303-10; Crit Care Med 2003; 31; 946-55) . Sepsis and related disorders are the chief cause of multiple organ failure and death in critically ill. Mortality associated with severe sepsis and septic shock ranges btween 30% and 60% (Crit care Med 2003; 31; 946-55) . Septic Shock Pathophysiology -In sepsis infection triggers a systemic inflammatory cascade by activation of neutrophils, endothelial cells and coagulation pathway. These release mediators and cytokines (eg., IL10, Thromboxane, TNF etc.) which have direct effect on cellular mitochondrial metabolic activity. Septic shock is primarily a form of distributive shock characterized by ineffective tissue O2 delivery and & tissue O2 extraction (cytopathic hypoxia). Inappropriate peripheral vasodilatation occurs despite preserved or increased cardiac output. The vasodilation alters the microcirculation leading to mitochondrial dysfunction and impairment of oxidative phosphorylation leading t increased rate fo cellulr apoptosis and organ failure. All the major organ system of the body gets involved leading to multi organ failure. The mortality in such cases may go upto 80%. The main organ failure involves adult respiratory distress syndrome (ARDS), acute renal failure (ARF) and coagulopathy. Management of Septic Shock -The septic shock is a challenge to an intensivist and the main management strategies are: 1. Hamodynamic Stablilization, 2. Infection Control, 3. Modulation of host response and supportive care. A number of treatment alternatives are available for management of septic shock. All the treatment modalities of septic shock were studied and based on best available evidences an international surviving sepsis guidelines were formulated for management of severe sepsis and septic shock to improve outcome in sepsis. ( Early diagnosis and therapy are important in the management of critically ill patients with sepsis and systemic inflammation. The ideal parameter for diagnosis and monitoring the progress of sepsis should be sensitive for the diagnosis of systemic inflammation, specific for the diagnosis of infection and correlate well with the severity of inflammation. Procalcitonin (PCT), a precursor of calcitonin has been proposed as a marker of severity of sepsis. Our objective was to assess the use of PCT for the diagnosis of severity of infection and also to assess its prognostic value. PCT was analyzed by immunoluminometric assay (BRAHMS) in fifty ICU patients. Serum PCT concentrations increased significantly with the increasing severity of the inflammatory response to infection. As compared to other inflammatory markers like Interleukin 6, Tumor Necrosis Factor a and high sensitivity C-reactive Protein, PCT was found to be a better (p<0.001) prognostic indicator. PCT measurements were helpful in differentiating between viral and bacterial infections (with systemic manifestations) as well. Serial measurements of PCT are useful in order to monitor response to therapy. Together with good clinical judgement and judicious use of antimicrobial agents, PCT should serve as a valuable adjunct in the management of sepsis.
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